Cat No. | Products Name (INN Index) | INN Name | SAbDab Target/Gene Name | Format |
GMP-Bios-ab-093 | Pre-Made Caplacizumab biosimilar, Nanobody, Anti-VWF Antibody: Anti-F8VWF/VWD therapeutic antibody | Caplacizumab | VWF | Nanobody |
GMP-Bios-ab-188 | Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 therapeutic antibody | Envafolimab | PDL1 | Single Domain Variable Fragment;H |
GMP-Bios-ab-307 | Pre-Made Letolizumab biosimilar, Single Domain Variable Fragment;H, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody | Letolizumab | CD40LG | Single Domain Variable Fragment;H |
GMP-Bios-ab-326 | Pre-Made Lulizumab biosimilar, Single Domain Variable Fragment;L, Anti-CD28 Antibody: Anti-Tp44 therapeutic antibody | Lulizumab | CD28 | Single Domain Variable Fragment;L |
GMP-Bios-ab-445 | Pre-Made Placulumab biosimilar, Single Domain Variable Fragment (VL + Fc), Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Placulumab | TNFA | Single Domain Variable Fragment (VL) + Fc |
GMP-Bios-ab-689 | Pre-Made Rimteravimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Rimteravimab | SARS-CoV-2 Spike RBD | Mixed Nanobody (VHH-CH2-CH3 dimer) |